Arkolith/Insider Trading/AGRX/Form 4

Coiante Scott M

Chief Financial OfficerAGILE THERAPEUTICS INC (AGRX) · full profile →Form 4 · filed Aug 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2024Disposed to issuer(D)5K$1.52$8K0
Aug 26, 2024Disposed to issuer(D)15K$1.52$23K5K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-092946) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML